Treatment response, survival and safety profile of transarterial chemoembolization using different sizes of drug-eluting beads in hepatocellular carcinoma patients with portal vein tumor thrombus

Clinics and Research in Hepatology and Gastroenterology - Tập 46 - Trang 101819 - 2022
Tianshi Lyu1, Hang Yao1, Jian Wang1, Li Song1, Xiaoqiang Tong1, Yinghua Zou1
1Department of Interventional and Vascular Surgery, Peking University First Hospital, Beijing, China

Tài liệu tham khảo

Liu, 2018, Hepatocellular carcinoma with portal vein tumor involvement: best management strategies, Semin Liver Dis, 38, 242, 10.1055/s-0038-1666805

Manzano-Robleda Mdel, 2015, Portal vein thrombosis: what is new?, Ann Hepatol, 14, 20, 10.1016/S1665-2681(19)30797-5

Zhang, 2015, The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus, Int J Surg, 20, 8, 10.1016/j.ijsu.2015.05.009

Lu, 2019, Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west, Lancet Gastroenterol Hepatol, 4, 721, 10.1016/S2468-1253(19)30178-5

Facciorusso, 2018, Drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma: current state of the art, World J Gastroenterol, 24, 161, 10.3748/wjg.v24.i2.161

Hagan, 2019, Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods, Eur J Pharm Sci, 136, 10.1016/j.ejps.2019.05.021

Lee, 2020, Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?, Diagn Interv Radiol, 26, 230, 10.5152/dir.2019.19261

Guiu, 2012, Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. drug-eluting beads, J Hepatol, 56, 609, 10.1016/j.jhep.2011.09.012

Wang, 2020, A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: a meta-analysis of six randomized controlled trials, J Cancer Res Ther, 16, 243, 10.4103/jcrt.JCRT_504_19

Zhang, 2019, Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety, BMC Cancer, 19, 1162, 10.1186/s12885-019-6386-6

Wu, 2018, CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study, World J Surg Oncol, 16, 69, 10.1186/s12957-018-1368-8

Zhou, 2021, Safety and efficacy of drug-eluting bead transarterial chemoembolization with CalliSpheres(R) microsphere for hepatocellular carcinoma with portal vein tumor thrombus: a preliminary study, J Cancer, 12, 4522, 10.7150/jca.54650

Tang, 2021, Efficacy and safety of transarterial chemoembolization in elderly patients of advanced hepatocellular carcinoma with portal vein tumor thrombus: a retrospective study, Front Oncol, 11

Agarwala, 2000, Congenital hepatoportal arteriovenous fistula: report of a case, Surg Today, 30, 268, 10.1007/s005950050057

Llovet, 1999, Prognosis of hepatocellular carcinoma: the BCLC staging classification, Semin Liver Dis, 19, 329, 10.1055/s-2007-1007122

Liang, 2020, Comparison of chemoembolization with CalliSpheres((R)) microspheres and conventional chemoembolization in the treatment of hepatocellular carcinoma: a multicenter retrospective study, Cancer Manag Res, 12, 941, 10.2147/CMAR.S187203

Ma, 2019, Comparison of treatment efficacy and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres((R)) microspheres and conventional transarterial chemoembolization as first-line treatment in hepatocellular carcinoma patients, Am J Transl Res, 11, 7456

Zhao, 2019, Comparison of treatment response, survival and safety between drug-eluting bead transarterial chemoembolization with CalliSpheres(R) microspheres versus conventional transarterial chemoembolization in treating hepatocellular carcinoma, J BUON, 24, 1150

Duan, 2020, Arsenic trioxide-eluting Callispheres beads is more effective and equally tolerant compared with arsenic trioxide/lipiodol emulsion in the transcatheter arterial chemoembolization treatment for unresectable hepatocellular carcinoma patients, Eur Rev Med Pharmacol Sci, 24, 1468

Peng, 2020, The comprehensive analysis of efficacy and safety of CalliSpheres((R)) drug-eluting beads transarterial chemoembolization in 367 liver cancer patients: a multiple-center, Cohort Study. Oncol Res, 28, 249, 10.3727/096504019X15766663541105

Fidelman, 2019, Prospective Phase II trial of drug-eluting bead chemoembolization for liver transplant candidates with hepatocellular carcinoma and marginal hepatic reserve, J Hepatocell Carcinoma, 6, 93, 10.2147/JHC.S206979

Li, 2019, Drug-eluting bead transarterial chemoembolization (TACE) vs conventional TACE in treating hepatocellular carcinoma patients with multiple conventional TACE treatments history: a comparison of efficacy and safety, Medicine (Baltimore), 98, e15314, 10.1097/MD.0000000000015314

Thông tin
Thông tin xuất bản

Clinics and Research in Hepatology and Gastroenterology

Tập 46

101819

Thông tin tác giả